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skeletal muscle disorders (Tüzün et al., 2006). We
recently found that changes in gene expression
of these cytokines and muscle sensitivity to them
differed between IUGR and control rats (Cadaret
et al., 2017), and that maternal inflammation
induced fetal leukocyte adaptations, increasing
gene expression of TNFα and its receptor TNFR1,
but decreasing gene expression of IL-6 receptor.
Both cytokines also regulate myoblast proliferation and differentiation outside of inflammatory
states (Al-Shanti et al., 2008). These findings indicate TNFα and IL-6 are essential factors in proper
growth and development of muscle, and thus, we
postulate that expression and sensitivity changes
contribute to decreased muscle growth capacity in
IUGR fetuses. The objective of this study was to
determine the effects of cytokines on fetal myoblast function and to determine if altered responsiveness is intrinsic in IUGR myoblasts, which
would represent a potential adaptive mechanism
for reduced muscle mass in IUGR offspring.

INTRODUCTION
Intrauterine growth restriction (IUGR) is a
leading cause of perinatal morbidity and mortality (Alisi et al., 2011). Skeletal muscle growth is
disproportionately reduced in IUGR fetuses and
offspring (Padoan et al. 2004; Yates et al. 2014).
These individuals present with reduced muscle
mass and increased risk for metabolic disorders at
all stages of life (Godfrey and Barker, 2000; Yates
et al. 2016.). Muscle growth requires proliferation,
differentiation, and fusion of myoblasts (muscle
stem cells) to form muscle fibers early in gestation
and to increase myonuclear content of existing
fibers during late gestation and after birth (Yates
et al., 2014). These processes can be disrupted
by inflammation, which is a potential factor in
impaired muscle development in the IUGR fetus
(Yates et al., 2012; Cadaret et al., 2017). Tumor
necrosis factor-alpha (TNFα) and interleukin
6 (IL-6) are potent multifunctional cytokines
involved in inflammatory and noninflammatory
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Animals and Myoblast Isolation
The following experiments were approved by
the Institutional Animal Care and Use Committees
at the University of Nebraska-Lincoln and The
University of Arizona which are both are accredited
by AAALAC International. Columbia-Rambouillet
ewes carrying singleton pregnancies were used to
S44

S45

WSASAS graduate competition

create IUGR fetuses (n = 7); placental insufficiency was
induced by exposing ewes to elevated ambient temperatures (35–40 °C, 35% RH) from 40 to 95 d of gestational
age (dGA), as previously described (Yates et al., 2014).
Control fetuses (n = 7) were from pair-fed ewes maintained at 25 °C. Ewes were necropsied at 134 ± 1 dGA
and myoblasts were isolated from fetal hindlimb muscle as described (Yates et al., 2014). Briefly, muscle was
finely minced, digested (Protease type XIV from Strept.
griseus; Sigma), and serial-centrifuged to isolate myoblasts, which were stored in liquid nitrogen until used.
Myoblast Functional Studies
Myoblast isolates were preplated in DMEM
(Gibco) + 10% fetal bovine serum (FBS, Atlas
Biologicals) for 2 h (37 °C; 95% O2, 5% CO2) to
yield ≥96% pure populations (Yates et al., 2014).
Cells were plated at 5,000 cells well−1 on fibronectin-coated six-well culture plates, grown for 3 d in
growth media (DMEM + 20% FBS), and then incubated for 24 h in growth media containing either no
additive (basal), TNFα (20 ng/mL; Sigma), or IL-6
(1 ng/mL; Sigma). Myoblasts were then pulse-labeled with EdU for 2 h and fixed in 4% PFA for 10 min.
A second set of myoblasts (10,000 cells well−1) were
plated as described above and cultured for 4 d in
differentiation media (DMEM + 2% FBS) with the
same three treatments described above.
Immunocytochemistry
Myoblasts incorporating EdU (i.e., replicating)
were identified by staining in suspension (ClickIT
EdU). Differentiated myoblasts were identified by
staining for myogenin (F5B; 1:50; BD Pharmingen)

or desmin (DE-U-10; 1:250; GeneTex). Primary
antibodies diluted in Permeablize/Block Buffer
(PBS + 5% FBS 0.5% Saponin + 2% bovine serum
albumin) were applied for 1 h at room temperature,
followed by 1-h incubation at room temperature
with secondary affinity purified anti-mouse IgG
PE-Conjugate antibody (1:250; Cell Signaling). All
samples were analyzed on a zEPI flow cytometer
(ORFLO Technologies), with gates set from negative controls.
Statistical Analysis
Data were analyzed for effects due to treatment,
incubation condition, and their interaction using the
Mixed procedure in SAS (SAS Institute, Cary NC)
with culture condition as a repeated variable. Two replicates per incubation condition were performed for
each fetus and averaged. Values are expressed as mean
percentages ± SE and fetus is the experimental unit.
RESULTS
Myoblast Proliferation
A treatment × incubation condition interaction was observed (P < 0.05) for proliferation rates
(Figure 1). Proliferation was greater (P < 0.05) in
control compared to IUGR myoblasts in basal and
IL-6 spiked media but was similar between control
and IUGR myoblasts in TNFα-spiked media. In control myoblasts, proliferation was decreased (P < 0.05)
after incubation in media spiked with either TNFα
or IL-6 compared to basal media. However, proliferation rates in IUGR myoblasts were similar among
basal, IL-6, and TNFα-spiked media.

Figure 1. Proliferation in IUGR fetal myoblasts incubated with TNFα (20 ng mL−1) or IL-6 (1 ng mL−1). Cells were pulsed with EdU for 2 h.
means with different superscripts differ (P < 0.05).

a,b,c
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Myoblast Differentiation
The percentages of myogenin-positive myoblasts were less (P < 0.05) for IUGR populations
than controls regardless of incubation condition
(Figure 2). Myogenin-positive percentages were
similar between basal and IL-6–spiked media
and were decreased (P < 0.05) by TNFα-spiked
media regardless of treatment group. A treatment × incubation condition interaction was
observed (P < 0.05) for desmin-positive myoblasts (Figure 3). Percentages of desmin-positive
myoblasts were less (P < 0.05) for IUGR populations compared to controls when incubated in
basal media but did not differ when incubated in

IL-6– or TNFα-spiked media. For control myoblasts, desmin-positive percentages were greatest
(P < 0.05) in basal media and least (P < 0.05)
in TNFα-spiked media. For IUGR myoblasts,
desmin-positive percentages did not differ among
media conditions.
DISCUSSION
In this study, we show that TNFα and IL-6 have
multifunctional effects on fetal myoblast dynamics, and that IUGR fetal myoblasts have inherent
changes in responsiveness to these cytokines. Both
cytokines decreased proliferation in control myoblasts but not in IUGR myoblasts, which indicates a

Figure 2. Myogenin expression in IUGR myoblasts after 3 d in differentiation media (2% FBS). Myoblasts were differentiated in media containing no additive (basal), TNFα (20 ng mL−1), or IL-6 (1 ng mL−1). a,b,cMeans with different superscripts differ (P < 0.05).

Figure 3. Desmin expression in IUGR myoblasts after 3 d in differentiation media (2% FBS). Myoblasts were differentiated in media containing
no additive (basal), TNFα (20 ng mL−1), or IL-6 (1 ng mL−1). a,b,cMeans with different superscripts differ (P < 0.05).
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lost capacity to respond to these functional regulators
and helps to explain their intrinsic functional deficits
(Yates et al., 2012, 2016; Brown, 2014). Cytokine
effects on differentiation were variable, with IL-6 not
affecting myogenin-positive myoblasts but reducing
desmin-positive myoblasts in controls. Conversely,
TNFα reduced both myogenin and desmin-positive
control myoblasts, indicating that it might be a more
potent regulator of fetal myoblasts. Neither cytokine
affected differentiation in IUGR myoblasts, however, which further demonstrates desensitization to
cytokine regulation. These data indicate that TNFα
and IL-6 contribute to dynamic changes in myoblast
proliferation and differentiation rates.
Intrinsically reduced function in IUGR myoblasts controls muscle growth, which is beneficial
under the hostile conditions of maternal stress but
detrimental after birth. This adaptation allows the
growing fetus to selectively mitigate the effects of
cytokines, which are increased in the IUGR intrauterine environment (Cadaret et al., 2017). After
birth, however, IUGR muscle is unable to respond
adequately to the (noninflammatory) regulation by
these cytokines that is essential for proper growth
and development (Al-Shanti et al., 2008). TNFα is
a particularly critical factor in muscle growth regulation (Collins and Grounds, 2001), and differential responsiveness in IUGR myoblasts may help
to explain reduced muscle mass and smaller fibers
observed with IUGR (Yates et al., 2016), as well as
impaired glucose metabolism (Godfrey and Barker,
2000; Cadaret et al., 2017). Decreased proliferation
and differentiation in uncompromised myoblasts by
IL-6 is likely due to its ability to augment substrate
delivery by interacting with the IGF system and
to inhibit TNFα production by peripheral tissues
(Pedersen et al., 2008; Al-Shanti et al., 2008; Akash
et al., 2018), which is lost in IUGR myoblasts.
IMPLICATIONS
Fetal adaptations that result in IUGR also
impair the responsiveness of skeletal muscle stem
cells to critical regulation by inflammatory cytokines,
mostly likely due to chronic overexposure in utero.
Responses to TNFα and IL-6 are selectively absent
in IUGR myoblasts as a protective response to mitigate the effects of maternofetal stress. Our findings
show that IUGR fetal skeletal muscle adaptations
change the ability of myoblasts to respond to these
regulatory cytokines. These adaptations restrict
skeletal muscle growth which, although helpful to
fetal survival, contributes to reduced muscle mass
and insulin resistance in IUGR offspring.
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